Psoriasis is a chronic inflammatory skin disease that follows a relapsing and remitting course. It affects about two per cent of the UK population. Most patients have mild to moderate psoriasis that can be managed with topical treatment.

Nevertheless, the impact of psoriasis on quality of life can be as great as cancer, arthritis, hypertension, heart disease, diabetes or depression. A range of topical treatments are available for mild to moderate psoriasis and patients often require several products.

Given the complexity of treatment and the need to balance efficacy with tolerability, potential toxicity and feasibility of use, there is significant scope for medicines use reviews (MURs) for patients using prescribed treatment for mild to moderate psoriasis. Community pharmacy services can make an important contribution towards helping patients to self-manage with effective treatments.